Gene therapy for hypertension: Sense and antisense strategies

Expert Opinion on Biological Therapy

Volumn 1, Issue 4, 2001, Pages 655-662

  Ian Phillips, M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY DNA; LIPOSOME;

ADENO ASSOCIATED VIRUS; ANIMAL; CHEMISTRY; DNA VECTOR; ECONOMICS; GENE THERAPY; GENETICS; HUMAN; HYPERTENSION; METABOLISM; METHODOLOGY; PLASMID; REVIEW;

ANGIOTENSINOGEN; ANIMAL; DEPENDOVIRUS; DNA, ANTISENSE; GENE THERAPY; GENETIC VECTORS; HUMAN; HYPERTENSION; LIPOSOMES; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PLASMIDS;

EID: 0035409902     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.1.4.655     Document Type: Article

References (35)

1. KAPLAN NM: Clinical hypertension. Williams and Williams, Baltimore, (1998).
2. LIFTON RP: Molecular genetics of human blood pressure variation. Science (1996) 272:676-680.
3. GYURKOR.WIELBOD, PHILLIPS MI: Antisense inhibition of ATI receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Rrg. Pep.
4. PHILLIPS MI, WIELBO D, GYURKO R; Amisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes. Kidney IntL (1994) 46:1554-1556.
5. CHAO J, CHAO L: Kallikrein gene therapy: a new strategy for hypertensive diseases. Immunopharmacology (1997) 36(2-3):229236.
6. LIN KF, CHAO J, CHAO L:Atrial natriuretic peptide gene delivery attenuates Expert Opin. Biol. Ther. (2001) 1(4)
7. hypertension, cardiac hypertrophy, and renal injury in sale-sensitive rats. Hum. Gene Ther. (1998) 9:1429-1438.
8. CHAO J, JIM L, LIN KF, CHAO L: Adrcnomedullm gene delivery reduces blood pressure in spontaneously hypertensive rats. Hyptrttns. Rts. (1997) 20:2692-2677.
9. LIN KF, CHAO L, CHAD J: Prolonged reduction of high blood pressure with human nitric oxide synthase gene deliver)'. Hypertension (1997) 30:307-313.
10. DOBRZYNSKIE,YOSHIDAH,CHAOJ, CHAO L: Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats. Immunofharmacology (1999) 44:57-65.
11. ZHANGYC, BUIJD.SHENLP, PHILLIPS MI: Amisense inhibition of Beta-1-Adrcnoceptor mRNA in a single dose produces and profound and prolonged reduction in high blood pressure in spontaneously hypertensive rats. Circulation (2000) 101:682-688.
12. 1
13. antisense oligodeoxynucleotides. Hypertension (2000) 35(2):219-224.
14. JEUNEMATTRE X, SOUBRIER F, KOTELEVETSEV YV et oh Molecular basis of human hypertension: role of angiotensinogen. O//U992) 71:169-180.
15. WIELBO D, SIMON A, PHILLIPS MI, TDFFOLO S: Inhibition of hypertension by peripheral administration of antisense oligodeoxynucleotides. Hypertension (1996) 28:147-151.
16. MAKINO K, SUGANO M, OHTSUKA S, SAWADA S: Intravenous injection with antisense oligodeoxynucleotides against angiotensinogen decreases blood pressure in spontaneously hypertensive rats. Hypertension (1998) 31:1166-1170.
17. GYURKO R, IRAN D, PHILLIPS MI: Time course of inhibition of hypertension by antisense oligonucleotides targeted to ATj angiotensin receptor mRNA in spontaneously hypertensive rats. Am. J. Hypertension (1997) 10:56S-62S.
18. KAGIYAMA S, VARELA A, PHILLIPS MI, GALLI SM: Antisense inhibition of brain renin angiotensin system decreased blood pressure in chronic 2K-1C hypertensive rats. Hypertension ( 2001).
19. PENG J-F, KIMURA B, FREGLY MJ, PHILLIPS MI: Reduction of cold-induced hypertension by antisenense oligodeoxynucleotides to angiotensinogen mRNA and ATj receptor mRNA in brain and blood. Hypertension (1998) 31:13171323.
20. LIB, HUGHES JA, PHILLIPS MI: Uptake and efflux of intact antisense phosphore thioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells. Ncurochem. IntL (1996) 31(3):393-403.
21. CROOKE ST: Progress in antisense technology: the end of the beginning. Methods Enzym. (2000) 313(l):3-45.
22. WU P, PHILLIPS MI, BUIJ, TERWILLINGER EF: Adeno-associated viral vector mediated transgene integration in nondividing cells.J. ViroL (1998) 72(7):5919-5926.
23. TANG X, MOHUCZY D, ZHANG CY, KIMURA B, GALLISM, PHILLIPS MI: Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension. Am. J. PhysioL (1999) 277(6 Pt. 2):H2392H2399.
24. LYNCH KR, SIMNAD VI, BEN ARI ET, GARRISON JG Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension (1986) 8:540-543.
25. ZOLOTUKHIN S, POTTER M, HAUSWIRTH WW, GUYJ, MUZYCZKA NA: "Humanized" green fluorescent protein cDNA adapted for highlevel expression in mammalian cells.J. ViroL (1996) 70:4646-4654.
26. MOHUCZY D, GELBAND C, PHILLIPS MI: Antisense inhibition of ATI receptors in vascular smooth muscle cells using adeno-associated virus-based vector. Hypertension (1999) 33:354-359.
27. • Shows uptake and effectiveness of AS-
28. DNA delivered by AAV.
29. PHILLIPS MI: Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension (1997) 29:177-187.
30. KIMURA B, MOHUCZY D, TANG X, PHILLIPS MI: Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense. Hypertension ( 2001) 37(2):376-380.
31. IYERSN.LUD.KATOVICHM, RAIZADA MK: Chronic control of high blood pressure in the spontaneously hypertensive rats by delivery of angiotensin type 1 receptor antisense. Proc, NatL Acad. Sei. USA (1996) 93:9960-9965.
32. PHILLIPS MI, KIMURAB.ZHANGY-C, GELBAND CH: Gene therapy for hypertension: recombinant adenoassociated virus vector delivery of angiotensin type 1 receptor antisense in hypertensive double transgenic mice. Hypertension (2000) 36(4):P204.
33. CHAMPION HC, BIVALACQUA TJ, TOYODA K, HEISTAD DD, HYMAN AL, KADOWITZ PJ: In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxiainduced pulmonary hypertension in the mouse. Circulation (2000) 101(8):923-930.
34. REAVES PY, GELBAND CH, WANG H étal: Permanent prevention of hypertension by angiotensin II type 1 receptor antisense gene therapy. Circ. Res. (1999) 8&E44-E50.
35. PHILLIPS MI: Is gene therapy for hypertension possible? Hypertension (1999) 33:8-13.